Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN401102 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 32 (IL32) (Isoform 4) antibody (HRP)
- Antibody type
- Polyclonal
- Antigen
- Full length recombinant human IL-32A protein
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Horseradish Peroxidase
- Epitope
- Isoform 4
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/mL (by UV absorbance at 280 nm)
- Storage
- Prior to reconstitution store at 2-8°C. Following reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references IL-32-dependent effects of IL-1beta on endothelial cell functions.
Molecular characterization of IL-32 in human endothelial cells.
Interleukin-32 expression in the pancreas.
Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection.
Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 10;106(10):3883-8
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 10;106(10):3883-8
Molecular characterization of IL-32 in human endothelial cells.
Kobayashi H, Lin PC
Cytokine 2009 Jun;46(3):351-8
Cytokine 2009 Jun;46(3):351-8
Interleukin-32 expression in the pancreas.
Nishida A, Andoh A, Inatomi O, Fujiyama Y
The Journal of biological chemistry 2009 Jun 26;284(26):17868-76
The Journal of biological chemistry 2009 Jun 26;284(26):17868-76
Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection.
Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J, Zhu Y
European journal of immunology 2009 Apr;39(4):1019-24
European journal of immunology 2009 Apr;39(4):1019-24
No comments: Submit comment
No validations: Submit validation data